Biomarin Pharmaceutical (BMRN) Buildings (2010 - 2013)
Biomarin Pharmaceutical's (BMRN) quarterly Buildings came in at $159.1 million in Q4 2013, up 9.97% YoY from $144.7 million in Q4 2012, and up 3.01% on a QoQ basis from $154.5 million in Q3 2013.
Biomarin Pharmaceutical (BMRN) Buildings (2010 - 2013) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 4 years of Buildings data on file, last reported at $159.1 million in Q4 2013.
- Quarterly Buildings rose 9.97% year-over-year to $159.1 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $159.1 million (up 9.97% YoY) and the FY2013 annual result came in at $159.1 million, up 9.97% from the prior year.
- Buildings rose to $159.1 million in Q4 2013, from $154.5 million in the prior quarter.
- In the past five years, Buildings ranged from a high of $159.1 million in Q4 2013 to a low of $138.0 million in Q4 2010.
- A 4-year average of $146.1 million and a median of $144.2 million in 2012 frame the typical range for Buildings.
- Annual changes were most pronounced in 2012 — Buildings grew 2.27% — and 2013, when it rose 9.97%.
- Tracing BMRN's Buildings over 4 years: stood at $138.0 million in 2010, then increased by 2.51% to $141.5 million in 2011, then gained by 2.27% to $144.7 million in 2012, then climbed by 9.97% to $159.1 million in 2013.
- The last three Buildings figures came in at $159.1 million (Q4 2013), $154.5 million (Q3 2013), and $147.0 million (Q2 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 159.13 Mn |
| Sep 30, 2013 | 154.48 Mn |
| Jun 30, 2013 | 147.00 Mn |
| Mar 31, 2013 | 146.55 Mn |
| Dec 31, 2012 | 144.70 Mn |
| Sep 30, 2012 | 143.77 Mn |
| Jun 30, 2012 | 143.02 Mn |
| Mar 31, 2012 | 142.71 Mn |
| Dec 31, 2011 | 141.48 Mn |
| Dec 31, 2010 | 138.03 Mn |